Generic name:leuprolide acetate
Dosage form: injectable suspension, for subcutaneous use
Drug classes:Gonadotropin releasing hormones, Hormones / antineoplastics
Medically reviewed by Drugs.com. Last updated on Apr 1, 2022.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- How Supplied/Storage and Handling
- Patient Counseling Information
- Medication Guide
Indications and Usage for Fensolvi
Fensolvi is indicated for the treatment of pediatric patients 2 years of age and older with central precocious puberty (CPP).
Fensolvi Dosage and Administration
Dosing Information
Fensolvi must be administered by a healthcare professional.
The dose of Fensolvi is 45 mg administered by subcutaneous injection once every six months.
Discontinue Fensolvi treatment at the appropriate age of onset of puberty.
MEDICAL DEPARTMENTS
Cardiology
Pediatrics
Diabetes Care
Pre-natal Care
Ultrasound Echocardiogram